Hemodialysis clinical trials at UC Health
3 in progress, 1 open to eligible people

• A Comparison Study of the Experimental Human Acellular Vessel For Dialysis in End-Stage Renal Disease

  open to eligible people ages 18 years and up

  The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access

  at UC Davis UC Irvine UCLA UCSD UCSF

• A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

  Sorry, not yet accepting patients

  Hypothyroidism, defined by elevated thyrotropin (TSH) levels, is a common endocrine complication in chronic kidney disease patients, and prior evidence shows that higher TSH levels, even within the normal laboratory range, are strongly associated with impaired quality of life and cardiovascular disease in this population. Levothyroxine is one of the most frequently prescribed medications in chronic kidney disease, yet its efficacy and safety in these patients have not been well-studied. Hence, this study will investigate 1) whether levothyroxine improves patient-centered (e.g., health-related quality of life, physical performance) and 2) cardiovascular (e.g., systolic function) outcomes in dialysis patients, and 3) if thyroid hormone replacement exerts classic metabolic effects (i.e., changes in body fat and resting energy expenditure) in this population.

  at UC Irvine

• Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis

  Sorry, in progress, not accepting new patients

  The main purpose of this study is to compare the Human Acellular Vessel (HAV) with ePTFE grafts when used for hemodialysis access.

  at UC Irvine

Last updated: June 1, 2019